Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Shandong Boan Biotechnology Company., Limited. Class H ( (HK:6955) ) has provided an announcement.
Shandong Boan Biotechnology Co., Ltd. has announced its upcoming annual general meeting scheduled for June 5, 2025. Key agenda items include the approval of the 2024 annual reports, appointment of new directors, re-appointment of Ernst & Young as auditors, and granting the board a mandate to issue additional shares. These resolutions aim to strengthen the company’s governance and financial structure, potentially enhancing its market position and operational capabilities.
More about Shandong Boan Biotechnology Company., Limited. Class H
Shandong Boan Biotechnology Co., Ltd. is a biotechnology company based in China, primarily involved in the development and commercialization of biopharmaceutical products. The company focuses on innovative therapies and solutions within the biotechnology sector.
YTD Price Performance: 17.26%
Average Trading Volume: 4,277,718
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.86B
For detailed information about 6955 stock, go to TipRanks’ Stock Analysis page.